In Vitro Diagnostics: Technologies and Global Markets

Report Highlights

The global in vitro diagnostics (IVD) market should reach $102.4 billion by 2022 from $74.1 billion in 2017 at a compound annual growth rate (CAGR) of 6.7%, from 2017 to 2022.

Report Includes

• 52  data tables and 8 additional table
• An overview of the global markets and related technologies for in vitro diagnostics.
• Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
• Detailed coverage of application areas, end users, and factors influencing and inhibiting demand for IVD.
• Information about IVD products, including reagents, instruments, and data management software and services.
• A look at how the rise in the number of diseases like respiratory infections, hospital acquired infections (HAI), and sexually transmitted diseases are creating a constant need for infectious disease testing in hospitals and laboratories.
• Segmentation into immunochemistry, clinical chemistry, SMBG, POC, MDx, hematology, microbiology, hemostasis, and tissue diagnostics.
• Application analysis: Diabetes, infectious, oncology, cardiology, and neurology.
• Profiles of major players in the industry.
• Company profiles of major players in the industry, including: Abbott Diagnostics Inc., Beckman Coulter (Part Of Danaher), Roche Diagnostics Corp., Thermo Fisher Scientific Inc., Transasia Bio-Medicals

Report Scope

The scope of this study is global. BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, Korea, Taiwan, Africa, Australia, Brazil, and Russia, among others. The report also examines the IVD market drivers as well as restraints and challenges affecting its growth. Further, the report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the IVD industry through their best practices in the research and development of IVDs. Excluded from this study is diagnostic testing such as imaging, veterinary diagnostics and their associated products.

This study will provide information on these areas:

• Structure and current market size of the IVD market as outlined with forecasts through 2022.
• Impact of chronic diseases, growing and aging populations.
• Current technology and product suppliers and key innovations.
• A look at the IVD industry and trends affecting the market.
• Markets by each segment (immunochemistry, molecular diagnostics, POC tests, clinical microbiology, hematology and tissue diagnostics) provide a global overview showing market data for the U.S., Europe, Asia-Pacific and Latin America, Africa and the Middle East (LAAM) regions.
• Emerging opportunities and potential investment opportunity areas for IVD.
• Technology patent trends relating to IVD.
• Profiles for more than 20 companies in the industry with significant contributions and market shares.

Analyst Credentials

JON EVANS has been involved in business development and research for the biotechnology industry since 1984. He has been involved in sales, market research and strategy analysis with Fortune 500 clients - with a particular focus on business development challenges and strategies to optimize market performance. He holds a B.S. degree in biology from Rutgers University and MBA in business analysis from San Francisco State University.